부산대학교 도서관

Tsai, Pei-Yun; Lee, Min-Sik; Jadhav, Unmesh; Naqvi, Insia; Madha, Shariq; Adler, Ashley; Mistry, Meeta; Naumenko, Sergey; Lewis, Caroline A.; Hitchcock, Daniel S.; Roberts, Frederick R.; DelNero, Peter; Hank, Thomas; Honselmann, Kim C.; Oyarvide, Vicente Morales; Mino-Kenudson, Mari; Clish, Clary B.; Shivdasani, Ramesh A.; Kalaany, Nada Y.

Proceedings of the National Academy of Sciences of the United States of America, 2021 Mar 01. 118(10), 1-11.

Baird, Michael D.; Madha, Emad S.; Arnaouti, Matthew; Cahill, Gabrielle L.; Hewa Kodikarage, Sadeesh N.; Harris, Rachel E.; Murphy, Timothy P.; Bartel, Megan C.; Rich, Elizabeth L.; Pathirana, Yasar G.; Kim, Eungjae; Bain, Paul A.; Alswaiti, Ghassan T.; Ratnayake, Amila S.; Worlton, Tamara J.; Joseph, Michelle N.

International Journal of Surgery. Jun 01, 2024 110(6):3617-3632

A., Mahitha; S., Vijaykarthikesh; M. P., Brundha

International Journal of Medicine & Public Health. Oct-Dec2025, Vol. 15 Issue 4, p191-199. 9p.

Mena Report. August 31, 2016

Shields, Margaret; Remondelli, Mason H; Wang, Amy M; Barzanji, Natalia K; Wang, Jonathan; Madha, Emad S; Bradley, Matthew J; Walker, Patrick F; Graybill, John C

Journal of Surgical Case Reports; Nov2025, Vol. 2025 Issue 11, p1-3, 3p

Banerjee K. K.; Saxena M.; Kumar N.; Chen L.; Cavazza A.; Toke N. H.; O'Neill N. K.; Madha S.; Jadhav U.; Verzi M. P.; Shivdasani R. A.

Genes Dev

Gaynor L; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA.; Singh H; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Tie G; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Badarinath K; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Madha S; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Mancini A; Department of Molecular Oncology, Genentech, South San Francisco, CA, USA.; Bhattacharya S; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hoshino M; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry, Tokyo, Japan.; de Sauvage FJ; Department of Molecular Oncology, Genentech, South San Francisco, CA, USA.; Murata K; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Jadhav U; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Shivdasani RA; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. ramesh_shivdasani@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. ramesh_shivdasani@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. ramesh_shivdasani@dfci.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Mancha Madha, K. ; Gurumoorthy, P. ; Arul Antony, S. ; Ramalakshmi, N.

In Journal of Molecular Structure 5 September 2017 1143:478-486

Patare, Prasad M. ; Palekar, S.P. ; Deore, Sandhya S.

In Materials Today: Proceedings 2023 90 Part 1:287-291

Manieri E; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Tie G; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Malagola E; Division of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Columbia University Medical Center, New York, NY, 10032, USA.; Seruggia D; Department of Hematology, Boston Children's Hospital, Boston, MA, 02115, USA.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Madha S; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Maglieri A; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Huang K; Molecular Imaging Core and Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Fujiwara Y; Department of Hematology, Boston Children's Hospital, Boston, MA, 02115, USA.; Howard Hughes Medical Institute, Boston, MA, 02115, USA.; Zhang K; Department of Hematology, Boston Children's Hospital, Boston, MA, 02115, USA.; Orkin SH; Department of Hematology, Boston Children's Hospital, Boston, MA, 02115, USA.; Howard Hughes Medical Institute, Boston, MA, 02115, USA.; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA.; Wang TC; Division of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Columbia University Medical Center, New York, NY, 10032, USA.; He R; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; McCarthy N; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Shivdasani RA; Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. ramesh_shivdasani@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA. ramesh_shivdasani@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA. ramesh_shivdasani@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Madha, S.; Washko, G.; Cho, M. H.; Hunninghake, G. M.; Estepar, R. San Jose; Bowler, R. P.; Gerszten, R. E.; Lutz, S. M.; DeMeo, D. L.; Silverman, E. K.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE; MAY 1 2025, 211 pA6321 2p. Supplement: S

Tarantino G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ricker CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wang A; Harvard Medical School, Boston, MA, USA.; Ge W; Harvard Medical School, Boston, MA, USA.; Aprati TJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Huang AY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.; Madha S; Worcester Polytechnic Institute, Worcester, MA, USA.; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Shi Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Glettig M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Feng CH; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Frederick DT; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Freeman S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Holovatska MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Zimmer L; Department of Dermatology, University HospitalEssen, Essen, Germany.; Rösch A; Department of Dermatology, University HospitalEssen, Essen, Germany.; Zaremba A; Department of Dermatology, University HospitalEssen, Essen, Germany.; Livingstone E; Department of Dermatology, University HospitalEssen, Essen, Germany.; Jameson JC; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, USA.; Saghafian S; Harvard Kennedy School, Harvard University, Cambridge, MA, USA.; Lee A; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Zhao K; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Morris LGT; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Elmarakeby HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Al-Azhar University, Cairo, Egypt.; Schilling B; Department of Dermatology, University HospitalEssen, Essen, Germany.; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.; Giobbie-Hurder A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Vokes NI; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Flaherty KT; Massachusetts General Hospital, Boston, MA, USA.; Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Boland GM; Massachusetts General Hospital, Boston, MA, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Schadendorf D; Department of Dermatology, University HospitalEssen, Essen, Germany.; Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

Singh PNP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Gu W; Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.; Madha S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Lynch AW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; He R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Bhattacharya S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Muñoz Gomez M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Meyer CA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Zhou Q; Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: jqz4001@med.cornell.edu.; Shivdasani RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: ramesh_shivdasani@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE

Kathiresan, Km. (6-ANJA-PGM) AMS Author Profile; Sabarimalai Madha, S. (6-ANJA-PGM) AMS Author Profile

Contributions to Discrete Mathematics (Contrib. Discrete Math.) (20170101), 12, no. 1, 143-156. eISSN: 1715-0868.

Madha, Emad S.; Kane, Timothy D.; Manole, Mioara D.

Pediatric Emergency Care. Feb 01, 2018 34(2):e32-e34

Murata K.; Jadhav U.; Madha S.; van Es J.; Dean J.; Cavazza A.; Wucherpfennig K.; Michor F.; Clevers H.; Shivdasani R. A.

Cell Stem Cell. 26:377-390.e6

Wibowo, Madha Christian; Sardjono, Tri Arief

2015 International Conference on Information & Communication Technology and Systems (ICTS) Information & Communication Technology and Systems (ICTS), 2015 International Conference on. :35-40 Sep, 2015

Jadhav U.; Cavazza A.; Banerjee K. K.; Xie H.; O'Neill N. K.; Saenz-Vash V.; Herbert Z.; Madha S.; Orkin S. H.; Zhai H.; Shivdasani R. A.

Molecular Cell. 74:542-554.e5

Dr. Patil N. J.; R. S., Hardade